| Protein | Synonyms | Taxonomy |
|---|
| Renin | EC 3.4.23.15; Angiotensinogenase | Homo sapiens (human) |
| Type-1 angiotensin II receptor | AT1AR; AT1BR; Angiotensin II type-1 receptor; AT1 | Homo sapiens (human) |
| Type-2 angiotensin II receptor | Angiotensin II type-2 receptor; AT2 | Homo sapiens (human) |
| Angiotensin-converting enzyme 2 | EC 3.4.17.23; Angiotensin-converting enzyme homolog; ACEH; Angiotensin-converting enzyme-related carboxypeptidase; ACE-related carboxypeptidase; 3.4.17.-; Metalloprotease MPROT15 | Homo sapiens (human) |
| Angiotensinogen | Serpin A8 | Homo sapiens (human) |
| Vitamin D 25-hydroxylase | | Homo sapiens (human) |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | | Homo sapiens (human) |
| Angiotensin-converting enzyme | | Homo sapiens (human) |
| Compound | Description |
|---|
| angiotensin ii | An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. |
| calcitriol | The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. |
| cholecalciferol | Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24. |
| calcifediol | The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. |
| angiotensin i, ile(5)- | |
| 7-dehydrocholesterol | RN given refers to (3beta)-isomer; structure; main provitamin in skin that is converted by sunlight to cholecalciferol (vitamin D3) |